BIOMAT Database Logo BIOMAT Database Logo

Attempt to reduce the progestogen component in hormone therapy. 2006

Steven R Goldstein

UI MeSH Term Description Entries
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement
D015986 Confounding Factors, Epidemiologic Factors that can cause or prevent the outcome of interest but are not intermediate variables of the factor(s) under investigation. Confounding Factor, Epidemiologic,Confounding Factors, Epidemiological,Confounding Factors, Epidemiology,Confounding Variables,Confounding Variables, Epidemiologic,Confounding Variables, Epidemiological,Confounding Factor, Epidemiological,Confounding Factor, Epidemiology,Confounding Variable,Confounding Variable, Epidemiologic,Confounding Variable, Epidemiological,Epidemiologic Confounding Factor,Epidemiologic Confounding Factors,Epidemiologic Confounding Variable,Epidemiologic Confounding Variables,Epidemiological Confounding Factor,Epidemiological Confounding Factors,Epidemiological Confounding Variable,Epidemiological Confounding Variables,Epidemiology Confounding Factor,Epidemiology Confounding Factors,Variable, Confounding,Variable, Epidemiologic Confounding,Variable, Epidemiological Confounding,Variables, Confounding,Variables, Epidemiologic Confounding,Variables, Epidemiological Confounding

Related Publications

Steven R Goldstein
Importance of the progestogen added to the estrogen in hormone therapy.
December 2005, Climacteric : the journal of the International Menopause Society,
Steven R Goldstein
Attempt to control parturition in the sow using an oral progestogen.
November 1985, The Veterinary record,
Steven R Goldstein
Is combined estrogen/progestogen hormone therapy worth the risk?
September 2003, Climacteric : the journal of the International Menopause Society,
Steven R Goldstein
Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
August 1992, The Medical journal of Australia,
Steven R Goldstein
Progestogen in menopausal hormone therapy and breast cancer risk.
April 2024, Obstetrics & gynecology science,
Steven R Goldstein
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
October 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
Steven R Goldstein
Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review.
December 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Steven R Goldstein
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
February 1990, American journal of obstetrics and gynecology,
Steven R Goldstein
Gonadotropin-releasing hormone agonist and estrogen-progestogen replacement therapy.
October 1991, American journal of obstetrics and gynecology,
Steven R Goldstein
Progestogen intolerance and compliance with hormone replacement therapy in menopausal women.
January 1997, Human reproduction update,
Copied contents to your clipboard!